Company Filing History:
Years Active: 2024
Title: Innovator Spotlight: Xiaoling He
Introduction: Xiaoling He, a distinguished inventor from Suzhou, China, holds a notable patent in the pharmaceutical sector. With a strong focus on enhancing drug formulation, her innovative work is pivotal in advancing healthcare solutions.
Latest Patents: Xiaoling's patent, titled "Pharmaceutical composition containing alkynyl compound and preparation method and application thereof," reveals a groundbreaking approach to drug development. This composition involves an active pharmaceutical ingredient, specifically 3-((1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-benzamide, along with its acceptable pharmaceutical salts. The formulation includes various excipients such as diluents and lubricants, significantly enhancing the bioavailability and stability of the alkynyl compound, while also ensuring improved drug safety.
Career Highlights: Xiaoling has made substantial contributions to the pharmaceutical industry, primarily through her tenure at Ascentage Pharma (Suzhou) Co., Ltd. and Ascentage Pharma Group Corp Limited. Her expertise in drug formulation has made her a valued asset within these organizations, allowing her to influence the development of innovative pharmaceutical solutions.
Collaborations: Throughout her career, Xiaoling has collaborated with notable professionals, including Yanqiong Lin and Jianfeng Wen. These partnerships have facilitated the exchange of ideas and expertise, further driving innovation in her field.
Conclusion: Xiaoling He stands out as a formidable inventor in the pharmaceutical domain, with her patented works exemplifying the essence of innovation. Her contributions not only enhance the effectiveness of pharmaceutical compounds but also underscore the importance of collaboration in driving advancements in medicine. The future holds immense promise for her continued impact on Healthcare.